Ok

China's Kintor says interim analysis of COVID treatment trial misses statistical criteria

BEIJING, Dec 27 (Reuters) - China's Kintor Pharmaceutical Ltd(9939.HK)said data from a Phase III cli
China's Kintor says interim analysis of COVID treatment trial misses statistical criteria

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

举报

评论

  • 推荐
  • 最新
empty
暂无评论